Home > Insider Trading > Filing (0001181431-13-041159)

Filing Details

Accession Number:: 0001181431-13-041159
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-07-23 19:09:35
Reporting Period:: 2013-07-23

Filing Date:: 2013-07-23
Accepted Time:: 2013-07-23 19:09:35
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1302573	Oncomed Pharmaceuticals Inc	OMED	Pharmaceutical Preparations (2834)	383572512

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1553355	N. James Woody	C/O Oncomed Pharmaceuticals, Inc. 800 Chesapeake Drive Redwood City CA 94063		Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-07-23	8,947	$0.00	30,876	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2013-07-23	100,000	$0.00	100,000	No	4	C	Indirect	Directly owned by LVP I
Common Stock	Acquisiton	2013-07-23	65,476	$0.00	165,476	No	4	C	Indirect	Directly owned by LVP I
Common Stock	Acquisiton	2013-07-23	74,142	$0.00	239,618	No	4	C	Indirect	Directly owned by LVP I
Common Stock	Acquisiton	2013-07-23	7,937	$17.00	247,555	No	4	P	Indirect	Directly owned by LVP I
Common Stock	Acquisiton	2013-07-23	426,315	$0.00	426,315	No	4	C	Indirect	Directly owned by LVP II
Common Stock	Acquisiton	2013-07-23	279,135	$0.00	705,450	No	4	C	Indirect	Directly owned by LVP II
Common Stock	Acquisiton	2013-07-23	316,079	$0.00	1,021,529	No	4	C	Indirect	Directly owned by LVP II
Common Stock	Acquisiton	2013-07-23	33,834	$17.00	1,055,363	No	4	P	Indirect	Directly owned by LVP II
Common Stock	Acquisiton	2013-07-23	611,995	$0.00	611,995	No	4	C	Indirect	Directly owned by LVP III
Common Stock	Acquisiton	2013-07-23	692,994	$0.00	1,304,989	No	4	C	Indirect	Directly owned by LVP III
Common Stock	Acquisiton	2013-07-23	43,223	$17.00	1,348,212	No	4	P	Indirect	Directly owned by LVP III
Common Stock	Acquisiton	2013-07-23	30,599	$0.00	30,599	No	4	C	Indirect	Directly owned by Associates
Common Stock	Acquisiton	2013-07-23	34,649	$0.00	65,248	No	4	C	Indirect	Directly owned by Associates
Common Stock	Acquisiton	2013-07-23	2,161	$17.00	67,409	No	4	P	Indirect	Directly owned by Associates
Common Stock	Acquisiton	2013-07-23	15,299	$0.00	15,299	No	4	C	Indirect	Directly owned by Partners
Common Stock	Acquisiton	2013-07-23	17,324	$0.00	32,623	No	4	C	Indirect	Directly owned by Partners
Common Stock	Acquisiton	2013-07-23	1,080	$17.00	33,703	No	4	P	Indirect	Directly owned by Partners

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See Footnote
No	4	C	Indirect	Directly owned by LVP I
No	4	C	Indirect	Directly owned by LVP I
No	4	C	Indirect	Directly owned by LVP I
No	4	P	Indirect	Directly owned by LVP I
No	4	C	Indirect	Directly owned by LVP II
No	4	C	Indirect	Directly owned by LVP II
No	4	C	Indirect	Directly owned by LVP II
No	4	P	Indirect	Directly owned by LVP II
No	4	C	Indirect	Directly owned by LVP III
No	4	C	Indirect	Directly owned by LVP III
No	4	P	Indirect	Directly owned by LVP III
No	4	C	Indirect	Directly owned by Associates
No	4	C	Indirect	Directly owned by Associates
No	4	P	Indirect	Directly owned by Associates
No	4	C	Indirect	Directly owned by Partners
No	4	C	Indirect	Directly owned by Partners
No	4	P	Indirect	Directly owned by Partners

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2013-07-23	8,947	$0.00	8,947	$0.00
Common Stock	Series A Preferred Stock	Disposition	2013-07-23	100,000	$0.00	100,000	$0.00
Common Stock	Series A Preferred Stock	Disposition	2013-07-23	426,315	$0.00	426,315	$0.00
Common Stock	Series B Preferred Stock	Disposition	2013-07-23	65,476	$0.00	65,476	$0.00
Common Stock	Series B Preferred Stock	Disposition	2013-07-23	279,135	$0.00	279,135	$0.00
Common Stock	Series B Preferred Stock	Disposition	2013-07-23	611,995	$0.00	611,995	$0.00
Common Stock	Series B Preferred Stock	Disposition	2013-07-23	30,599	$0.00	30,599	$0.00
Common Stock	Series B Preferred Stock	Disposition	2013-07-23	15,299	$0.00	15,299	$0.00
Common Stock	Series B-1 Preferred Stock	Disposition	2013-07-23	74,142	$0.00	74,142	$0.00
Common Stock	Series B-1 Preferred Stock	Disposition	2013-07-23	316,079	$0.00	316,079	$0.00
Common Stock	Series B-1 Preferred Stock	Disposition	2013-07-23	692,994	$0.00	692,994	$0.00
Common Stock	Series B-1 Preferred Stock	Disposition	2013-07-23	34,649	$0.00	34,649	$0.00
Common Stock	Series B-1 Preferred Stock	Disposition	2013-07-23	17,324	$0.00	17,324	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Footnotes

Each share of Series A, Series B and Series B-1 Preferred Stock automatically converted on a one-to-one basis into Common Stock immediately prior to the consummation of the Issuer's initial public offering July 23, 2013.
The shares are held by the Woody/Mann-Moore Family 2006 Trust.
The reported securities are owned directly by each of LVP Life Science Ventures I, L.P. ("LVP I"), LVP Life Science Ventures II, L.P. ("LVP II"), LVP Life Science Ventures III, L.P ("LVP III"), LVP III Associates, L.P. ("Associates") and LVP III Partners, L.P. ("Partners"). LVP GP I, LLC ("GP I") is the general partner of LVP I, LVP GP II, LLC ("GP II") is the general partner of LVP II and LVP GP III, LLC ("GP III") is the general partner of LVP III, Associates and Partners. The reporting person, a member of GP I, GP II and GP III, shares voting and investment power with respect to these shares but disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein.
The securities are immediately convertible.
The expiration date is not relevant to the conversion of these securities.